Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Thirona is a specialized medical technology company that develops advanced artificial intelligence solutions for high-precision medical image analysis. Based in Nijmegen, Netherlands, the company focuses on transforming clinical workflows in pulmonology and ophthalmology through automated quantification of 3D and 2D images. Their flagship platform, LungQ, provides detailed anatomical analysis of lung structures to support the treatment of chronic diseases such as COPD, asthma, and cystic fibrosis. In the ophthalmic space, their RetCAD software utilizes deep learning to screen for diabetic retinopathy, glaucoma, and age-related macular degeneration. Thirona's technology is widely utilized by pharmaceutical companies and medical device manufacturers to validate treatment efficacy in clinical trials. By bridging the gap between academic innovation and clinical application, Thirona aims to improve patient outcomes through more accurate and personalized diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Thirona.